“bicycle-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
Roche Spinout Nimble Therapeutics Bags $10M to Find New Peptide Drugs 04/30/19 Wisconsin
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Coming to Boston Was a “No-Brainer”: Xconomy’s Newcomer Award Finalists 09/05/17 Boston
Atlas Venture Unveils New $350M Fund for Seed Biotech Investments 06/29/17 Boston
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Bicycle Therapeutics Maps Course to Clinic Backed by $52M Investment 06/01/17 Boston
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets 04/13/16 Boston
London Notebook: Conversations Inside The Biomedical Golden Triangle 12/15/15 National
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Ensemble Adds to Cast of Partners With Alexion Deal 07/18/13 Boston
Page 1 of 1